TCL Archive In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982 June 11, 1982
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Niederhuber says his job is easy, but times are hard: NCI may need to cut up to $150 million. December 9, 2005
TCL Archive NCI Plans To Recomplete CCOP; Future Direction To Be Discuss At DCPC Board, NCAB Meetings January 17, 1986
